CMPX Compass Therapeutics, Inc. logo

CMPX Compass Therapeutics, Inc.

Healthcare
$2.07+7.25%ClosedMarket Cap: $286.3M

As of 2026-05-25

Insider Statistics (Q2 2026)

Acquisitions

4

Dispositions

0

Buy/Sell Ratio

0.00

Net Shares

+80,000

Shares Acquired

80,000

Shares Disposed

0

Total Bought ($)

$2.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu Apr 30Lerner Neilofficer: Chief Accounting OfficerBuy15,000$1.89397,500
Thu Apr 30Anderman Jonathanofficer: General CounselBuy25,000$1.89196,000
Wed Apr 29Lerner Neilofficer: Chief Accounting OfficerSell15,000$1.89397,500
Wed Apr 29Anderman Jonathanofficer: General CounselSell25,000$1.89196,000
Tue Feb 10Schuetz Thomas J.director, officer: CHIEF EXECUTIVE OFFICERSell36,687$6.526,603,336
Mon Jan 12Schuetz Thomas J.director, officer: CHIEF EXECUTIVE OFFICERSell46,777$5.356,640,023
Mon Jan 05Sirard Cynthiaofficer: Chief Medical OfficerSell1,000,000$5.171,000,000
Mon Jan 05Shin Barryofficer: CFOSell670,000$5.17670,000
Mon Jan 05Shin Barryofficer: CFOSell125,000$5.17525,000
Mon Jan 05Schuetz Thomas J.director, officer: CEOSell2,000,000$5.172,000,000
Mon Jan 05Schuetz Thomas J.director, officer: CEOSell250,000$5.176,686,800
Mon Jan 05Prasad Arjunofficer: Chief Commercial OfficerSell1,000,000$5.171,000,000
Mon Jan 05LINDAHL RICHARD SdirectorSell90,000$5.1790,000
Mon Jan 05Chiniara EllendirectorSell90,000$5.1790,000